p38α stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis

Molecular and Cellular Neuroscience

Volumn 26, Issue 2, 2004, Pages 354-364

  Ackerley, Steven ^a   Grierson, Andrew J ^a,b   Banner, Steven ^a   Perkinton, Michael S ^a   Brownlees, Janet ^a,c   Byers, Helen L ^a   Ward, Malcolm ^a   Thornhill, Paul ^a,d   Hussain, Kader ^a   Waby, Jennifer S ^b   Anderton, Brian H ^a   Cooper, Jonathan D ^a   Dingwall, Colin ^b   Leigh, P Nigel ^a   Shaw, Christopher E ^a   Miller, Christopher C J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; COPPER ZINC SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EMBRYO; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; MOUSE; NEUROFILAMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; ANIMAL; CELL STRAIN COS1; DISEASE MODEL; ENZYMOLOGY; FETUS; GENETICS; METABOLISM; MOTONEURON; MUTATION; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; TRANSGENIC MOUSE;

MUS MUSCULUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; COS CELLS; DISEASE MODELS, ANIMAL; FETUS; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 14; MITOGEN-ACTIVATED PROTEIN KINASES; MOTOR NEURONS; MUTATION; NERVE DEGENERATION; NEUROFILAMENT PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; SUPEROXIDE DISMUTASE;

EID: 4644362726     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2004.02.009     Document Type: Article

References (69)

1. Ackerley S., Grierson A.J., Brownlees J., Thornhill P., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C.J. Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol. 150:2000;165-175
2. Ackerley S., Thornhill P., Grierson A.J., Brownlees J., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C.J. Neurofilament heavy chain side-arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 161:2003;489-495
3. Bajaj N.P., Miller C.C.J. Phosphorylation of neurofilament heavy-chain side-arm fragments by cyclin-dependent kinase-5 and glycogen synthase kinase-3α in transfected cells. J. Neurochem. 69:1997;737-743
4. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD and peroxynitrite. Nature. 364:1993;584
5. Betts J.C., Blackstock W.P., Ward M.A., Anderton B.H. Identification of phosphorylation sites on neurofilament proteins by nanoelectrospray mass spectrometry. J. Biol. Chem. 272:1997;12922-12927
6. Brownlees J., Yates A., Bajaj N.P., Davis D., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C.J. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J. Cell Sci. 113:2000;401-407
7. Brownlees J., Ackerley S., Grierson A.J., Jacobsen N.J., Shea K., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet. 11:2002;2837-2844
8. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18:1997;327-338
9. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.L. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1998;1851-1854
10. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology. 18:1968;841-851
11. Chin S.S.M., Liem R.K.H. Transfected rat high-molecular-weight neurofilament (NF-H) coassembles with vimentin in a predominantly nonphosphorylated form. J. Neurosci. 10:1990;3714-3726
12. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 302:2003;113-117
13. Collard J.-F., Cote F., Julien J.-P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 375:1995;61-64
14. Cuenda A., Alonso G., Morrice N., Jones M., Meier R., Cohen P., Nebreda A.R. Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells. EMBO J. 15:1996;4156-4164
15. Cuenda A., Cohen P., Buee-Scherrer V., Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:1997;295-305
16. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., et al. Amyotrophic-lateral- sclerosis and structural defects in Cu, Zn superoxide-dismutase. Science. 261:1993;1047-1051
17. Dérijard B., Raingeaud J., Barrett T., Wu I.-H., Han J., Ulevitch R.J., Davis R.J. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;682-685
18. Durham H.D., Roy J., Dong L., Figlewicz D.A. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol. 56:1997;523-530
19. Elhanany E., Jaffe H., Link W.T., Sheeley D.M., Gainer H., Pant H.C. Identification of endogenously phosphorylated KSP sites in the high-molecular-weight rat neurofilament protein. J. Neurochem. 63:1994;2324-2335
20. Giasson B.I., Mushynski W.E. Aberrant stress-induced phosphorylation of perikaryal neurofilaments. J. Biol. Chem. 271:1996;30404-30409
21. Giasson B.I., Mushynski W.E. Study of proline-directed kinases involved in phosphorylation of the heavy neurofilament subunit. J. Neurosci. 17:1997;9466-9472
22. Guidato S., Tsai L.-H., Woodgett J., Miller C.C.J. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J. Neurochem. 66:1996;1698-1706
23. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.-X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 264:1994;1772-1775
24. Hirano A., Donnenfeld H., Sasaki S., Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43:1984;461-470
25. Hisanaga S., Ishiguro K., Uchida T., Okumura E., Okano T., Kishimoto T. Tau protein kinase II has a similar characteristic to cdc2 kinase for phosphorylating neurofilament proteins. J. Biol. Chem. 268:1993;15056-15060
26. Hu J.H., Chernoff K., Pelech S., Krieger C. Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice. J. Neurochem. 85:2003;422-431
27. Itoh T., Sobue G., Ken E., Mitsuma T., Takahashi A., Trojanowski J.Q. Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: system-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy. Acta Neuropathol. 83:1992;240-245
28. Johnston J.A., Dalton M.J., Gurney M.E., Kopito R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12571-12576
29. Julien J.-P., Mushynski W.E. Multiple phosphorylation sites in mammalian neurofilament polypeptides. J. Biol. Chem. 257:1982;10467-10470
30. Jung C., Yabe J.T., Shea T.B. C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity. Brain Res. 856:2000;12-19
31. Kriz J., Nguyen M., Julien J. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 10:2002;268-278
32. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:2001;807-869
33. Lee V.M.-Y., Carden M.J., Schlaepfer W.W., Trojanowski J.Q. Monoclonal antibodies distinguish several differently phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of rats. J. Neurosci. 7:1987;3474-3488
34. Lee V.M.-Y., Otvos L., Carden M.J., Hollosi M., Deitzschold B., Lazzarini R.A. Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc. Natl. Acad. Sci. U. S. A. 85:1988;1998-2002
35. Lee S.H., Park J., Che Y., Han P.L., Lee J.K. Constitutive activity and differential localization of p38alpha and p38beta MAPKs in adult mouse brain. J. Neurosci. Res. 60:2000;623-631
36. cdc2. J. Biol. Chem. 267:1992;25922-25926
37. Lovestone S., Reynolds C.H., Latimer D., Davis D.R., Anderton B.H., Gallo J.-M., Hanger D., Mulot S., Marquardt B., Stabel S., et al. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4:1994;1077-1086
38. Maruyama M., Sudo T., Kasuya Y., Shiga T., Hu B.R., Osada H. Immunolocalization of p38 MAP kinase in mouse brain. Brain Res. 887:2000;350-358
39. Miller C.C.J., Ackerley S., Brownlees J., Grierson A.J., Jacobsen N.J.O., Thornhill P. Axonal transport of neurofilaments in normal and disease states. Cell. Mol. Life Sci. 59:2002;323-330
40. Napolitano E.W., Chin S.S.M., Colman D.R., Liem R.K. Complete amino acid sequence and in vitro expression of rat NF-M, the middle molecular weight neurofilament protein. J. Neurosci. 7:1987;2590-2599
41. Nguyen M.D., Lariviere R.C., Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron. 30:2001;135-147
42. Nixon R.A., Paskevich P.A., Sihag R., Thayer C. Phosphorylation on carboxy terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: Influences on regional neurofilament spacing, and axon caliber. J. Cell Biol. 126:1994;1031-1046
43. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1996;1247-1255
44. Raoul C., Estevez A., Nishimune H., Cleveland D., deLapeyriere O., Henderson C., Haase G., Pettmann B. Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron. 35:2002;1067-1083
45. Reynolds C.H., Nebreda A.R., Gibb G.M., Utton M.A., Anderton B.H. Reactivating kinase/p38 phosphorylates τ protein in vitro. J. Neurochem. 69:1997;191-198
46. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 92:1995;689-693
47. Robertson J., Beaulieu J.M., Doroudchi M.M., Durham H.D., Julien J.P., Mushynski W.E. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine TNFα J. Cell Biol. 155:2001;217-226
48. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in the Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62
49. Rouleau G.A., Clark A.W., Rooke K., Pramatarova A., Krizus A., Suchowersky O., Julien J.P., Figlewicz D. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;128-131
50. Sanchez I., Hassinger L., Sihag R.K., Cleveland D.W., Mohan P., Nixon R.A. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo. Selective role of site-specific phosphorylation. J. Cell Biol. 151:2000;1013-1024
51. Sasaki T., Taoka M., Ishiguro K., Uchida A., Saito T., Isobe T., Hisanaga S. In vivo and in vitro phosphorylation at Ser-493 in the glutamate (E)-segment of neurofilament-H subunit by glycogen synthase kinase 3beta. J. Biol. Chem. 277:2002;36032-36039
52. Schmidt M.L., Carden M.J., Lee V.M., Trojanowski J.Q. Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. Lab. Invest. 56:1987;282-294
53. Shetty K.T., Link W.T., Pant H.C. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6844-6848
54. Sobue G., Hashizume Y., Yasuda T., Mukai E., Kumagai T., Mitsuma T., Trojanowski J.Q. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol. 79:1990;402-408
55. Standen C.L., Perkinton M.S., Byers H.L., Kesavapany S., Lau K.F., Ward M., McLoughlin D., Miller C.C. The neuronal adaptor protein Fe65 is phosphorylated by mitogen-activated protein kinase (ERK1/2). Mol. Cell. Neurosci. 24:2003;851-857
56. Sternberger L.A., Sternberger N.H. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments. Proc. Natl. Acad. Sci. U. S. A. 80:1983;6126-6130
57. Sun D., Leung C.L., Liem R.K.H. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by cdk-5 and p35. J. Biol. Chem. 271:1996;14245-14251
58. Tortarolo M., Veglianese P., Calvaresi N., Botturi A., Rossi C., Giorgini A., Migheli A., Bendotti C. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell. Neurosci. 23:2003;180-192
59. Trotti D., Rolfs A., Danbolt N.C., Brown R.H.J., Hediger M.A. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2:1999;427-433
60. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., Lee V.M.Y. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. U. S. A. 93:1996;3155-3160
61. Van Den Bosch L., Tilkin P., Lemmens G., Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. NeuroReport. 13:2002;1067-1070
62. Veeranna, Amin N.D., Ahn N.G., Jaffe H., Winters C.A., Grant P., Pant H.C. Mitogen-activated protein kinases (Erk1, 2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J. Neurosci. 18:1998;4008-4021
63. Wiedau-Pazoz M., Goto J.J., Rabizadeh S., Gralla E.D., Roe J.A., Valentine J.S., Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518
64. Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2:1999;50-56
65. Wong P.C., Pardo C., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterised by vacuolar degeneration of mitochondria. Neuron. 14:1995;1105-1116
66. Yabe J.S., Chylinski T., Wang F.-S., Pimenta A., Kattar S.D., Linsley M.-D., Chan W.K.-H., Shea T.B. Neurofilaments consist of distinct populations that can be distinguished by c-terminal phosphorylation, bundling and axonal transport rates in axonal neurites. J. Neurosci. 21:2001;2195-2205
67. Yuasa T., Ohno S., Kehrl J.H., Kyriakis J.M. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273:1998;22681-22692
68. Zhang P., Tu P.-H., Abtahian F., Trojanowski J.Q., Lee V.M.-Y. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139:1997;1307-1315
69. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y.S., Ona V., Li M.W., Sarang S., Liu A.S., Hartley D.M., Du C.W., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 417:2002;74-78